APA

Walle L. V., Stowe I. B., Šácha P., Lee B. L., Demon D., Fossoul A., Van Hauwermeiren F., Saavedra P. H. V., Šimon P., Šubr V., Kostka L., Stivala C. E., Pham V. C., Staben S. T., Yamazoe S., Konvalinka J., Kayagaki N. & Lamkanfi M. (2019). Correction: MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition. : PLoS biology.

Chicago

Walle Lieselotte Vande, Stowe Irma B, Šácha Pavel, Lee Bettina L, Demon Dieter, Fossoul Amelie, Van Hauwermeiren Filip, Saavedra Pedro H V, Šimon Petr, Šubr Vladimír, Kostka Libor, Stivala Craig E, Pham Victoria C, Staben Steven T, Yamazoe Sayumi, Konvalinka Jan, Kayagaki Nobuhiko and Lamkanfi Mohamed. 2019. Correction: MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition. : PLoS biology.

Harvard

Walle L. V., Stowe I. B., Šácha P., Lee B. L., Demon D., Fossoul A., Van Hauwermeiren F., Saavedra P. H. V., Šimon P., Šubr V., Kostka L., Stivala C. E., Pham V. C., Staben S. T., Yamazoe S., Konvalinka J., Kayagaki N. and Lamkanfi M. (2019). Correction: MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition. : PLoS biology.

MLA

Walle Lieselotte Vande, Stowe Irma B, Šácha Pavel, Lee Bettina L, Demon Dieter, Fossoul Amelie, Van Hauwermeiren Filip, Saavedra Pedro H V, Šimon Petr, Šubr Vladimír, Kostka Libor, Stivala Craig E, Pham Victoria C, Staben Steven T, Yamazoe Sayumi, Konvalinka Jan, Kayagaki Nobuhiko and Lamkanfi Mohamed. Correction: MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition. : PLoS biology. 2019.